AELIX Therapeutics
About AELIX Therapeutics
The startup develops a therapeutic vaccine utilizing a T-cell immunogen designed to elicit a robust immune response against HIV. This approach aims to provide a potential cure for HIV infection, offering patients a pathway to overcome a chronic viral disease.
What does AELIX Therapeutics do?
The startup develops a therapeutic vaccine utilizing a T-cell immunogen designed to elicit a robust immune response against HIV. This approach aims to provide a potential cure for HIV infection, offering patients a pathway to overcome a chronic viral disease.
Where is AELIX Therapeutics located?
AELIX Therapeutics is based in Barcelona, Spain.
How much funding has AELIX Therapeutics raised?
AELIX Therapeutics has raised 13210000.
- Location
- Barcelona, Spain
- Funding
- 13210000
- Employees
- 3 employees
- Major Investors
- CDTI